NEXGEL Inc. (NXGL)
3.85
0.40 (11.59%)
At close: Jan 15, 2025, 11:05 AM
Company Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels.
Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.
The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.
NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
NEXGEL Inc.
| Country | United States |
| IPO Date | Dec 22, 2021 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Adam R. Levy |
Contact Details
Address: 2150 Cabot Boulevard West Langhorne, Pennsylvania United States | |
| Website | https://nexgel.com |
Stock Details
| Ticker Symbol | NXGL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001468929 |
| CUSIP Number | 65344E107 |
| ISIN Number | US65344E1073 |
| Employer ID | 26-4042544 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Adam R. Levy | Chief Executive Officer, President & Director |
| Adam E. Drapczuk III | Chief Financial Officer |
| Gregory Robb | Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 08, 2025 | 4 | Filing |
| Jan 06, 2025 | 4 | Filing |
| Jan 06, 2025 | 3 | Filing |
| Jan 06, 2025 | 8-K | Current Report |
| Dec 23, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |